Cancer, a common and devastating disease process in both people and animals, can be difficult to detect until it is in relatively advanced stages – when it is more challenging to treat and control. Rametrix Technologies, Inc. is now leveraging its platform technology – Rametrix Urine Molecular Fingerprinting® - in...
People helping animals, animals helping people
Several breeds of dogs, including Bernese Mountain Dogs, Golden Retrievers, German Shepherd Dogs, and short-legged terriers (West Highland White Terriers, Scottish Terriers) have a significantly higher incidence of specific cancers than other breeds of dogs. For example, up to 50% of Bernese Mountain Dogs may develop aggressive soft tissue tumors...
Multicenter Study of Canine Visceral Hemangiosarcoma
Working with the sponsorship of the Morris Animal Foundation and colleagues at five major veterinary medical academic centers in the US, Europe, and South America, RTI has launched a 24-month study of an aggressive tumor of the spleen and heart (visceral hemangiosarcoma) using Rametrix Urine Molecular Fingerprinting.
Urine Molecular Fingerprinting of Human Prostate Cancer
Prostate cancer is the most common cancer diagnosis in men and the second leading cause of male cancer death in the United States, with approximately 35,000 deaths per year. Screening with Prostate Specific Antigen testing (PSA) and early detection of prostate cancer has been demonstrated to save lives. However, MRI-guided...
Human Soft Tissue Sarcoma Study Initiated
Knowledge gained from this critical work on aggressive soft tissue tumors in Bernese Mountain Dogs is being directly translated into similar efforts to improve outcomes of these devastating tumors in people. Working in concert with physicians, scientists, and healthcare teams at Atrium Health/Levine Cancer Center and Atrium Health Wake Forest...